FE Baraka Dori Farm, Llc Pharmaceutical Import Profile — Uzbekistan (DGFT 2022–2026)

Name: FE Baraka Dori Farm, Llc Pharmaceutical Import Records from India — 2 Products, $2.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

FE Baraka Dori Farm, Llc — Pharmaceutical Importer Profile (2026) | 2 Products, $2.6M Trade | TransData Nexus

FE Baraka Dori Farm, Llc

Pharmaceutical Importer · Uzbekistan · Antifungals Focus · $2.6M Total Trade · DGFT Verified

FE Baraka Dori Farm, Llc is a pharmaceutical importer based in Uzbekistan with a total trade value of $2.6M across 2 products in 2 therapeutic categories. Based on 99 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. FE Baraka Dori Farm, Llc sources from 1 verified Indian supplier, with Kusum Healthcare Private Limited accounting for 100.0% of imports.

FE Baraka Dori Farm, Llc — Import Portfolio & Supplier Network

FE Baraka Dori Farm, Llc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to FE Baraka Dori Farm, Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Kusum Healthcare Private Limited	$7.5M	372	100.0%

FE Baraka Dori Farm, Llc sources from 1 verified Indian supplier across 234 distinct formulations. The sourcing is highly concentrated — Kusum Healthcare Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Dermazole shampoo 20x8 ML (ketoconazole2% w/v solution) b.no.1005464 d.o.m.12.2024 d.o.e.11.2028/ b.no. 1005532	$200.0K	4
Oxapin-300 tablets 3x10s (oxcarbazepine300mg tablets) batch no. 1005445 dom -11.2024 doe -	$200.0K	4
Nimid forte tablets 10x1x10s	$189.6K	4
Dermazole shampoo 50 ML (ketoconazole	$159.2K	4
Mezacar-400 sr tablets 5x10s (carbamazepine BP 400MG tablets ) batch no. 1005410 dom - 11.2024 doe -	$111.5K	4
Fusys gel 30GM(fluconazole gel 0.5% w/w)	$109.5K	3
Dermazole shampoo 100 ML (ketoconazole	$102.8K	3
Dermazole shampoo 50 ML (ketoconazole 2%w/v solution ) batch no. 1005648 dom -01.2025 doe -	$101.1K	4
Dermazole shampoo 100 ML (ketoconazole 2% w/v solution) batch no.1005174,1005235, 1005236,1005237,1005380	$100.0K	2
L-cet tablets 10x10s (levocetrizine 5mgtablets) b.no.1005186 dom-10.2024 doe-09.2027/b.no.1005346,1005354	$100.0K	2
Confundus tablets 10x10s (carbidopa andlevodopa tablets BP) batch no.1004078 &1004079 dom- 05.2024 doe-	$100.0K	2
Montular-10 tablets 10x10s (montelukasttablets 10 MG) b.no.1004003 dom-04.2024doe-03.2026,b.no.1004195	$100.0K	2
Tigeron-500 tablets 1x5s (levofloxacin500mg tablets ) batch no. 1003896 dom- 04.2024 doe-	$100.0K	2
Tigeron-750 tablets 1x5s (levofloxacin750mg tablets) batch no.1003907 & 1003908 dom- 04.2024 doe-	$100.0K	2
Ascozin tablets 10x10s (ascorbic acid and zinc tablets) b.no.1005743,1005747,1005748 dom- 01.2025 doe-	$100.0K	2

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ketoconazole	Antifungals	$2.5M	91	4.2%	5
2	Biotin	Vitamins & Supplements	$51.2K	8	2.1%	8

FE Baraka Dori Farm, Llc imports 2 pharmaceutical products across 2 categories into Uzbekistan totaling $2.6M.

FE Baraka Dori Farm, Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

FE Baraka Dori Farm, Llc is a pharmaceutical importer based in Tashkent, Uzbekistan. The company specializes in the procurement of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily sourced from India. With a total import value of $2.6 million USD across 99 shipments, FE Baraka Dori Farm demonstrates a focused approach to sourcing specific pharmaceutical products. The company's portfolio is concentrated on two therapeutic categories: antifungals and vitamins & supplements, with antifungals comprising 98% of their imports. This strategic focus indicates a targeted effort to meet the demand for these therapeutic areas within the Uzbekistani market.

2Distribution Network

While specific details about FE Baraka Dori Farm's warehouse locations and logistics capabilities are not publicly disclosed, the company's consistent import activity suggests a well-established distribution network within Uzbekistan. The primary port of entry for these pharmaceutical products is Tashkent, the capital city, which serves as a central hub for distribution throughout the country. Given the volume and frequency of imports, it is likely that the company operates multiple warehouses to facilitate efficient storage and distribution, ensuring timely delivery to various regions within Uzbekistan.

3Industry Role

FE Baraka Dori Farm, Llc functions as a primary wholesaler in Uzbekistan's pharmaceutical supply chain. By importing finished pharmaceutical formulations and distributing them domestically, the company plays a crucial role in ensuring the availability of essential medications across the country. Their focus on specific therapeutic categories, particularly antifungals, positions them as a key player in meeting the healthcare needs related to these treatments.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — FE Baraka Dori Farm, Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with 100% of their pharmaceutical imports originating from a single supplier, KUSUM HEALTHCARE PRIVATE LIMITED in India. This single-source dependency could pose risks, such as supply chain disruptions due to geopolitical issues, regulatory changes, or operational challenges faced by the supplier. However, the consistent volume of imports and the long-standing relationship indicated by the data suggest a stable and reliable partnership. The strategic choice to concentrate sourcing from one supplier may also allow for better negotiation terms and streamlined logistics.

2Supply Chain Resilience

FE Baraka Dori Farm's supply chain resilience appears to be closely tied to the stability of KUSUM HEALTHCARE PRIVATE LIMITED. The absence of backup suppliers and the lack of diversification in sourcing could make the company vulnerable to disruptions. Additionally, the limited diversity in imported formulations, with only 234 unique products, may restrict the company's ability to adapt to changing market demands or regulatory requirements. Ensuring that KUSUM HEALTHCARE maintains high standards of quality and compliance with international regulations is essential for mitigating potential risks.

Strategic Implications

Importing Pharmaceuticals into Uzbekistan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Uzbekistan

1Regulatory Authority & Framework

In Uzbekistan, the State Sanitary and Epidemiological Surveillance Service (SSESS) is the primary regulatory authority overseeing pharmaceutical imports. Key legislation governing pharma imports includes the Law on Medicines and Pharmaceutical Activities, which outlines the requirements for the import, registration, and distribution of pharmaceutical products. The marketing authorization pathway for Indian generics involves obtaining a certificate of conformity from the SSESS, ensuring that imported products meet the country's safety, efficacy, and quality standards.

2Import Licensing & GMP

Import licensing requirements in Uzbekistan stipulate that pharmaceutical importers must obtain an import license from the SSESS, which involves submitting detailed documentation about the products, including their composition, manufacturing process, and intended use. Recognition of Good Manufacturing Practice (GMP) certificates is crucial; certificates from recognized authorities such as the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S) are typically accepted. Additionally, importers must hold a wholesale distribution authorization to legally distribute pharmaceutical products within the country.

Quality & Labeling

FE Baraka Dori Farm, Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

FE Baraka Dori Farm's focus on importing antifungal medications, particularly ketoconazole, aligns with the therapeutic needs of the Uzbekistani population. The high import value of ketoconazole suggests a significant demand for antifungal treatments, possibly due to prevalent fungal infections or a lack of domestic production in this category. The inclusion of biotin in their portfolio indicates an interest in vitamins and supplements, catering to the growing health and wellness market in Uzbekistan.

2Sourcing Profile

The company's sourcing strategy is centered on generic drugs, primarily from India, which offers cost-effective manufacturing and a wide range of pharmaceutical products. The preference for finished pharmaceutical formulations allows for quicker market entry and reduces the complexities associated with raw material sourcing and manufacturing. India's established reputation in pharmaceutical manufacturing and its compliance with international quality standards make it a suitable partner for FE Baraka Dori Farm.

3Market Positioning

Based on its product mix, FE Baraka Dori Farm serves the wholesale distribution segment of the Uzbekistani pharmaceutical market. By importing and distributing specific therapeutic products, the company ensures that essential medications are available to pharmacies, hospitals, and clinics across the country, thereby supporting the overall healthcare infrastructure.

Seller's Guide — How to Become a Supplier to FE Baraka Dori Farm, Llc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Uzbekistani market by meeting the specific product requirements of FE Baraka Dori Farm. Gaps in the company's current sourcing include a limited range of imported formulations and a lack of diversification in suppliers. Potential suppliers can capitalize on these gaps by offering a broader range of products, ensuring compliance with Uzbekistani regulatory standards, and establishing reliable supply chains to meet the company's needs.

2Requirements & Qualifications

Indian exporters aiming to supply FE Baraka Dori Farm must obtain GMP certificates recognized by the SSESS, such as EU GMP, WHO GMP, or PIC/S. They must also ensure that their products comply with Uzbekistani labeling requirements, including the use of the Uzbek language and adherence to serialization mandates. Establishing a reliable supply chain capable of meeting the importer's volume and quality demands is essential.

3How to Approach

Frequently Asked Questions — FE Baraka Dori Farm, Llc

What products does FE Baraka Dori Farm, Llc import from India?

FE Baraka Dori Farm, Llc imports 2 pharmaceutical products across 2 categories. Top imports: Ketoconazole ($2.5M), Biotin ($51.2K).

Who supplies pharmaceuticals to FE Baraka Dori Farm, Llc from India?

FE Baraka Dori Farm, Llc sources from 1 verified Indian suppliers. The primary supplier is Kusum Healthcare Private Limited (100.0% of imports, $7.5M).

What is FE Baraka Dori Farm, Llc's total pharmaceutical import value?

FE Baraka Dori Farm, Llc's total pharmaceutical import value from India is $2.6M, based on 99 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does FE Baraka Dori Farm, Llc focus on?

FE Baraka Dori Farm, Llc imports across 2 categories. The largest: Antifungals (98.0%), Vitamins & Supplements (2.0%).

Get Full FE Baraka Dori Farm, Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.